SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001019687-15-002167
Filing Date
2015-05-28
Accepted
2015-05-27 17:32:18
Documents
3
Period of Report
2015-05-26
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 PHARMACYTE BIOTECH, INC. pharmacyte_8k-052615.htm 8-K 16650
2 LETTER OF ROBISON, HILL & CO. TO THE SEC DATED MAY 26, 2015 pharmacyte_8k-ex1601.htm EX-16.1 6714
3 GRAPHIC image_001.jpg GRAPHIC 1901
  Complete submission text file 0001019687-15-002167.txt   27463
Mailing Address 12510 PROSPERITY DRIVE, SUITE 310 SILVER SPRING MD 20904-1643
Business Address 12510 PROSPERITY DRIVE, SUITE 310 SILVER SPRING MD 20904-1643 (917) 595.2850
PharmaCyte Biotech, Inc. (Filer) CIK: 0001157075 (see all company filings)

IRS No.: 621772151 | State of Incorp.: NV | Fiscal Year End: 0430
Type: 8-K | Act: 34 | File No.: 333-68008 | Film No.: 15893297
SIC: 2833 Medicinal Chemicals & Botanical Products